Press releases for zangani

Zangani Begins Campaign to Petition Congress to Repeal Sarbanes-Oxley (SOX) Act (2007-01-24)
We have begun a movement to investigate the possibility of changing, or repealing entirely, the Sarbanes-Oxley Act of 2002. Please see link below for open letter and a signed petition that is growing by the minute. The Open Letter: http://www.zangani.com/sox The "Digg" submission http://www.digg.com/business_finance/Sarbanes_Oxley_Could_Be_A_Thing_of_the_Past_Open_Letter_to_Congress

Bio Korea 2006 (2006-05-10)
Zangani Investor Community announces Bio Korea 2006 in Seoul on September 6th-8th, 2006

Zangani Investor Community Announces Interview with Biophan Technologies, Inc. President Michael Weiner (2006-04-04)
Interview Available on Zangani Website and Via Podcast

ViRexx Announces Collaboration with Defence Research and Development Canada-Suffield to Expand Chimigen'TM' Platform Technology for Use in Biodefense (2006-03-31)
ViRexx Medical Corp. (TSX:VIR - News; AMEX:REX - News), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that it has entered into a research collaboration with Defence Research and Development Canada - Suffield (DRDC Suffield) to carry out research on applying ViRexx's proprietary Chimigen(TM) vaccine platform for biodefense.

Zangani Investor Community Announces Interview with ViRexx Medical Corporation President Marc Canton (2006-03-31)
Zangani Investor Community, an outsourced IR and Business Development firm specializing in small cap and micro cap companies announced today that it interviewed Marc Canton, President of ViRexx Medical Corporation (TSX:VIR; AMEX:REX), on March 23rd, 2006. Mr. Canton discussed latest stage drug candidates for treatment of ovarian cancer and chronic hepatitis B and C., as well as, the Company’s latest growth strategies and its listing on the AMEX

Biophan and Siemens AG Announce a Declaration of Intent for Strategic Collaboration on Advanced Interventional MRI Technology (2006-03-30)
Biophan-Europe to Enter into Negotiations for a Joint R&D Agreement with Siemens Medical Solutions MRI Division